HER2 Support Group Forums - View Single Post - BREAST CANCER UPDATE 7 of 2006:expert interviews

saleboat · 12-12-2006, 01:28 PM

If I understand the history of the herceptin trials correctly, they were massively overpowered because of advocacy groups, i.e., breast cancer advocacy groups were instrumental in getting as many patients included in the trial as possible. If it weren't for size of the trials, far fewer women would have had access to the drug. There weren't any other competitors to Herceptin at the time for adjuvent therapy, as far as I know.

12-12-2006, 01:28 PM	#5
saleboat Senior Member Join Date: Sep 2005 Location: NYC Posts: 250	If I understand the history of the herceptin trials correctly, they were massively overpowered because of advocacy groups, i.e., breast cancer advocacy groups were instrumental in getting as many patients included in the trial as possible. If it weren't for size of the trials, far fewer women would have had access to the drug. There weren't any other competitors to Herceptin at the time for adjuvent therapy, as far as I know. __________________ dx 4/05 @ 34 y.o. Stage IIIC, ER+ (90%)/PR+ (95%)/HER2+ (IHC 3+) lumpectomy-- 2.5 cm 15+/37 nodes (IVF in between surgery and chemo) tx dd A/C, followed by dd Taxol & Herceptin 30 rads (or was it 35?) Finished Herceptin on 7/24/06 Tamox livingcured.blogspot.com "Keep your face to the sunshine and you cannot see the shadow." -- Helen Keller